Traws Pharma, Inc. (TRAW) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 16, 2026 filed July 9, 2026 | Pauza Charles David Chief Science Officer Virology | $0 | 97,000 | 0% | No | |
|
|
||||||
| July 15, 2026 filed July 9, 2026 | CAUTREELS WERNER Director | $0 | 14,150 | 0% | No | |
|
|
||||||
| July 15, 2026 filed July 9, 2026 | Savchuk Nikolay Chief Operating Officer | $0 | 93,000 | 0% | No | |
|
|
||||||
| July 14, 2026 filed July 9, 2026 | STOVER JACK E Director | $0 | 14,150 | 0% | No | |
|
|
||||||
| July 14, 2026 filed July 9, 2026 | Dukes Iain D. Chief Executive Officer | $0 | 274,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free